Literature DB >> 33723378

O-GlcNAc modification of small heat shock proteins enhances their anti-amyloid chaperone activity.

Aaron T Balana1, Paul M Levine1, Timothy W Craven2, Somnath Mukherjee3, Nichole J Pedowitz1, Stuart P Moon1, Terry T Takahashi1, Christian F W Becker3, David Baker2, Matthew R Pratt4,5.   

Abstract

A major role for the intracellular post-translational modification O-GlcNAc appears to be the inhibition of protein aggregation. Most of the previous studies in this area focused on O-GlcNAc modification of the amyloid-forming proteins themselves. Here we used synthetic protein chemistry to discover that O-GlcNAc also activates the anti-amyloid activity of certain small heat shock proteins (sHSPs), a potentially more important modification event that can act broadly and substoichiometrically. More specifically, we found that O-GlcNAc increases the ability of sHSPs to block the amyloid formation of both α-synuclein and Aβ(1-42). Mechanistically, we show that O-GlcNAc near the sHSP IXI-domain prevents its ability to intramolecularly compete with substrate binding. Finally, we found that, although O-GlcNAc levels are globally reduced in Alzheimer's disease brains, the modification of relevant sHSPs is either maintained or increased, which suggests a mechanism to maintain these potentially protective O-GlcNAc modifications. Our results have important implications for neurodegenerative diseases associated with amyloid formation and potentially other areas of sHSP biology.

Entities:  

Year:  2021        PMID: 33723378     DOI: 10.1038/s41557-021-00648-8

Source DB:  PubMed          Journal:  Nat Chem        ISSN: 1755-4330            Impact factor:   24.427


  49 in total

1.  Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.

Authors:  Scott A Yuzwa; Xiaoyang Shan; Matthew S Macauley; Thomas Clark; Yuliya Skorobogatko; Keith Vosseller; David J Vocadlo
Journal:  Nat Chem Biol       Date:  2012-02-26       Impact factor: 15.040

2.  O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers.

Authors:  Scott A Yuzwa; Adrienne H Cheung; Mark Okon; Lawrence P McIntosh; David J Vocadlo
Journal:  J Mol Biol       Date:  2014-01-18       Impact factor: 5.469

3.  Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.

Authors:  Tiffany S Pinho; Sónia C Correia; George Perry; António Francisco Ambrósio; Paula I Moreira
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-11-06       Impact factor: 5.187

Review 4.  Protein O-GlcNAcylation: emerging mechanisms and functions.

Authors:  Xiaoyong Yang; Kevin Qian
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

5.  A Chemoenzymatic Histology Method for O-GlcNAc Detection.

Authors:  Aime Lopez Aguilar; Xiaomeng Hou; Liuqing Wen; Peng G Wang; Peng Wu
Journal:  Chembiochem       Date:  2017-12-05       Impact factor: 3.164

6.  O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

Authors:  Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Gerald W Hart; Cheng-Xin Gong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

7.  Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.

Authors:  Fei Liu; Jianhua Shi; Hitoshi Tanimukai; Jinhua Gu; Jianlan Gu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  Brain       Date:  2009-05-18       Impact factor: 13.501

8.  Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration.

Authors:  Andrew C Wang; Elizabeth H Jensen; Jessica E Rexach; Harry V Vinters; Linda C Hsieh-Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-12       Impact factor: 11.205

Review 9.  O-GlcNAcylation and neurodegeneration.

Authors:  Willayat Y Wani; John C Chatham; Victor Darley-Usmar; Lori L McMahon; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2016-08-04       Impact factor: 4.077

10.  O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease.

Authors:  Nicholas P Marotta; Yu Hsuan Lin; Yuka E Lewis; Mark R Ambroso; Balyn W Zaro; Maxwell T Roth; Don B Arnold; Ralf Langen; Matthew R Pratt
Journal:  Nat Chem       Date:  2015-10-12       Impact factor: 24.427

View more
  16 in total

1.  Finding the sweet spot for chaperone activity.

Authors:  Sheena E Radford; Theodoros K Karamanos
Journal:  Nat Chem       Date:  2021-05       Impact factor: 24.427

2.  RNA binding motif protein 3 (RBM3) promotes protein kinase B (AKT) activation to enhance glucose metabolism and reduce apoptosis in skeletal muscle of mice under acute cold exposure.

Authors:  Yang Liu; Hongzhao Shi; Yajie Hu; Ruizhi Yao; Peng Liu; Yuying Yang; Shize Li
Journal:  Cell Stress Chaperones       Date:  2022-09-23       Impact factor: 3.827

Review 3.  Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools.

Authors:  Isabelle Landrieu; Elian Dupré; Davy Sinnaeve; Léa El Hajjar; Caroline Smet-Nocca
Journal:  Front Chem       Date:  2022-05-12       Impact factor: 5.545

Review 4.  Tools, tactics and objectives to interrogate cellular roles of O-GlcNAc in disease.

Authors:  Charlie Fehl; John A Hanover
Journal:  Nat Chem Biol       Date:  2021-12-21       Impact factor: 16.174

5.  Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications.

Authors:  Antonieta L Salguero; Maggie Chen; Aaron T Balana; Nam Chu; Hanjie Jiang; Brad A Palanski; Hwan Bae; Katharine M Wright; Sara Nathan; Heng Zhu; Sandra B Gabelli; Matthew R Pratt; Philip A Cole
Journal:  ACS Chem Biol       Date:  2021-12-23       Impact factor: 5.100

Review 6.  O-GlcNAcylated peptides and proteins for structural and functional studies.

Authors:  Aaron T Balana; Stuart P Moon; Matthew R Pratt
Journal:  Curr Opin Struct Biol       Date:  2021-01-09       Impact factor: 7.786

Review 7.  Large Chaperone Complexes Through the Lens of Nuclear Magnetic Resonance Spectroscopy.

Authors:  Theodoros K Karamanos; G Marius Clore
Journal:  Annu Rev Biophys       Date:  2022-01-19       Impact factor: 19.763

8.  O-GlcNAc modification of MYPT1 modulates lysophosphatidic acid (LPA)-induced cell contraction in fibroblasts.

Authors:  Murielle M Morales; Nichole J Pedowitz; Matthew R Pratt
Journal:  J Biol Chem       Date:  2021-05-18       Impact factor: 5.157

9.  Analysis of pancreatic extracellular matrix protein post-translational modifications via electrostatic repulsion-hydrophilic interaction chromatography coupled with mass spectrometry.

Authors:  Dylan Nicholas Tabang; Yusi Cui; Daniel M Tremmel; Megan Ford; Zihui Li; Sara Dutton Sackett; Jon S Odorico; Lingjun Li
Journal:  Mol Omics       Date:  2021-10-11

Review 10.  Mechanistic roles for altered O-GlcNAcylation in neurodegenerative disorders.

Authors:  Aaron T Balana; Matthew R Pratt
Journal:  Biochem J       Date:  2021-07-30       Impact factor: 3.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.